Skip to main content
State of Wisconsin flag

Official website of the State of Wisconsin

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

We have refreshed our website: Tell us what you think

Use the "Site Feedback" link found at the bottom of every webpage. We look forward to hearing from you!

COVID-19: Therapeutics Distribution

Most people who get COVID-19 experience mild illness and can recover at home. A combination of rest, hydration, and over-the-counter medications can help relieve symptoms. But some people with severe illness may need medical care and treatment to get better. There are medications authorized by the U.S. Food and Drug Administration (FDA) for those who are at risk of developing severe COVID-19. This medication – oral antiviral pills – have proven highly effective at keeping people from becoming very ill, being hospitalized, or dying from COVID-19. 

The federal government currently provides allocations of many of these medications to states for distribution to retail pharmacies, health systems, community health clinics, and Test to Treat sites. The Wisconsin Department of Health Services (DHS) distributes COVID-19 oral antiviral treatments to health systems, clinics, and pharmacies throughout the state. There are also commercially available treatments. These entities can then prescribe and administer the medications for people with COVID-19. 

Free COVID-19 Treatment Telehealth consultations

DHS offers a free COVID-19 Treatment Telehealth service for Wisconsinites ages 18 and older who test positive for COVID-19 to help them access COVID-19 treatments. Learn more about it on our telehealth webpage.

The following information is provided for health systems, pharmacists, and other health care providers to find information about the distribution of COVID-19 treatments across Wisconsin, how to join the federal Test to Treat program, and other resources regarding the provision of COVID-19 treatments. If you are a member of the public hoping to learn more about available treatments, please visit the COVID-19: Treatments and Medications webpage.

 

To order COVID-19 therapeutics, eligible pharmacies and health care providers must place an order through the U.S. Department of Health and Human Services Health Partner Ordering Portal (HPOP). To set up a free account in this service, email DHSOperations@wisconsin.gov for detailed instructions.

 

The state map below shows locations that have received shipments of COVID-19 treatments authorized for emergency use by the Food and Drug Administration. The Wisconsin Department of Health Services is partnering with the federal government on a Test to Treat program as part of the National COVID-19 Preparedness Plan. If your pharmacy, clinic, or organization is interested in becoming a Test to Treat site, please review this checklist to see if you meet eligibility requirements.

The therapeutics locator map below shows Test to Treat locations and over 700 pharmacies where treatents are available in the state. The number of courses at each location is listed.

This map shows locations that have received allocations of oral antiviral pills:

  • PAXLOVID™
  • Renal PAXLOVID™
  • Lagevrio™ (molnupiravir)

For a nationwide map of therapeutics distribution locations, visit the Department of Health and Human Services website.


Related resources

211 Wisconsin

Call 211 or 877-947-2211 to get referrals for thousands of services across Wisconsin. For COVID-19 questions, text COVID to 211-211. Language assistance is available.

Resilient Wisconsin

Get help learning how to manage stress and adapt to change with services and support from organizations across the state.

Helpful resources

Find help with housing, income, food, employment, health care, mental health concerns, safety at home, and more—in multiple languages.
Last revised January 31, 2023